In the wake of the 2026 ESMO Breast Cancer conference, researchers and clinicians are parsing a wealth of data aimed at refining treatment precision and improving patient quality ...

Participants on weekly injections of 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks, and 45.3% of participants achieved ≥ 30% weight loss.

Many breast cancer drugs block estrogen receptors inside cancer cells. Blocking the receptors early in disease progression staves off metastasis. But most patients with advanced disease eventually ...

A new Salk Institute study suggests estrogen-related receptors could be a key to repairing energy metabolism and muscle fatigue. Across the body, tiny bean-shaped structures called mitochondria turn ...

When activated in ovarian cancer cells, the receptor for the body's primary stress hormone alters the tumor environment in ...